Briefcases -- BIOMET MDL 2391 M2A HIP IMPLANTS- -- BIOMET MDL 2391 M2A HIP IMPLANT INITIAL CASE MANAGEMENT ORDERS FROM 2012

Documents: BIOMET MDL 2391 M2A HIP IMPLANT INITIAL CASE MANAGEMENT ORDERS FROM 2012

ZIMMER BIOMET M2A HIP IMPLANT LITIGATION 

(BIOMET MDL 2391 M2A HIP IMPLANT)

 

The Biomet M2A-Magnum Hip is a metal-on-metal hip replacement system that has been implanted in patients throughout the United States. Although it was promoted for active and younger patients, reported problems suggest that the artificial hip implant may be prone to fail within a few years of surgery.

While typical hip implants consist of components made of metal and plastic, the Biomet Magnum has three all-metal components, a metal femoral head, metal taper insert and metal acetabulum cup. As the metal parts rub against each other, microscopic shavings of metal may be released into the hip joint, which could cause inflammation, loosening and other problems associated with metal hip poisoning.

Potential signs of Biomet Magnum hip problems could include:

  • Unexplained Hip Pain

  • Swelling and Soft Tissue Damage

  • Unexplained Tumors

  • Difficulty Standing or Walking

  • Loosening of the Hip Implant

  • Additional Hip Revision Surgery

A surprising number of individuals throughout the United States have reported experiencing problems with the Biomet hip replacement, often involving loosening, dislocation, wear or failure of the implant due to the design of the device. Although the hip implant is expected to last more than 15 years, many individuals have required revision surgery within a few years to replace or correct problems with Biomet M2A Magnum hup implants.

According to allegations raised in Biomet M2A Magnum hip lawsuits, these problems were known to the device manufacturer, yet they continued to market the implant as safe and effective. Rather than issuing a Biomet Magnum hip replacement recall, the system was aggressively marketed as having advantages over other hip systems.

 

File Name Posted
Biomet MDL 2391 Memorandum of First Case Management Conference November 16, 2012 April 5, 2017
BIOMET MDL 2391 Order Regarding Plaintiffs Organizational Counsel 12-5-2012 April 5, 2017
BIOMET MDL 2391 Pretrial Order No. 1 Pro Hac Vice Application Requirements 11-16-2012 April 5, 2017
BIOMENT MDL 2391 CASE CONTACT DATA AND RELATED DEMOGRAPHICS April 5, 2017
BIOMET MDL 2391 Order Regarding Plaintiffs Organizational Counsel 12-5-2012.pdf April 5, 2017
BIOMET MDL 2391 Pretrial Order No. 1 Pro Hac Vice Application Requirements 11-16-2012.pdf April 5, 2017